I’ve in the past demonstrated both agonist and you will antagonist homobivalent ligands focusing on the latest melanocortin receptor system
I’ve in the past demonstrated both agonist and you will antagonist homobivalent ligands focusing on the latest melanocortin receptor system Results 40–41 Ligands targeting the melanocortin system have been implicated as potential therapeutics or used as pharmacological probes for a wide range of disease states including cancer, 42–46 skin pigmentation disorders, 47 social disorders, 48–49 […]